Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Adami, Eleonora Dr. (1) Akalin, Altuna Dr. (1) Bader, Michael Prof. Dr. (1) Begay-Müller, Valerie Dr. (1) Beule, Dieter Dr. (2) Birchmeier, Walter Prof. Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blüthgen, Nils (1) Costanza, Mariantonia Dr. (2) Dahlmann, Mathias Dr. (1) Daniel, Peter Prof. Dr. (1) Del Giudice, Simone (1) Franke, Vedran Dr. (1) Gerlach, Kerstin (1) Gotthardt, Michael Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Jarosch, Ernst Dr. (1) Keller, Ulrich Dr. med. (1) Kirchner, Marieluise Dr. (3) Landthaler, Markus Prof. Dr. (4) Lewin, Gary Prof. Dr. (1) Maatz, Henrike Dr. (1) Mathas, Stephan Dr. (14) Ohler, Uwe Prof. Dr. (1) Radke, Michael Dr. (1) Rajewsky, Klaus Prof. Dr. (2) Rajewsky, Nikolaus Prof. Dr. (4) Rehm, Armin Dr. (2) Rother, Franziska Dr. (1) Scheidereit, Claus Prof. Dr. (2) Selbach, Matthias Prof. Dr. (33) Singh, Manvendra Dr. (1) Sommer, Christian (2) Sommer, Thomas Prof. Dr. (1) Sporbert, Anje Dr. (1) Sprink, Thiemo Dr. (1) Stein, Ulrike Prof. Dr. (1) van Bentum, Mirjam (1) Walther, Wolfgang Prof. Dr. (1) Waltho, Anita (1) Wollert-Wulf, Brigitte (2) Wyler, Emanuel Dr. (2) Zauber, Henrik Dr. (4) Ziehm, Matthias Dr. (2) (-) Herzog, Margareta (1) (-) Janz, Martin Dr. (11) (-) Leutz, Achim Prof. Dr. (2) (-) Lusatis, Simone (1) (-) Müller, Thomas Dr. (1) 1999 (1) 2000 (1) 2002 (1) 2003 (3) 2004 (2) (-) 2005 (3) (-) 2006 (4) 2007 (2) 2008 (2) 2009 (3) (-) 2010 (1) 2011 (4) 2012 (2) 2013 (2) (-) 2014 (4) 2015 (2) 2016 (1) 2017 (4) 2018 (1) 2020 (4) (-) 2021 (3) 2022 (4) 2023 (6) 2024 (1) Bioinformatics and Omics Data Science (1) (-) Biology of Malignant Lymphomas (13) Developmental Biology / Signal Transduction (6) From Cell States to Function (1) Genetics and Genomics of Cardiovascular Diseases (1) Genetics of Metabolic and Reproductive Disorders (1) Immune Regulation and Cancer (2) Mechanism-based Cancer Therapies (1) Microenvironmental Regulation in Autoimmunity and Cancer (1) Molecular Physiology of Somatic Sensation (1) Protein Production and Characterization (1) (-) Proteome Dynamics (2) Proteomics (2) RNA Biology and Posttranscriptional Regulation (1) Systems Biology of Gene Regulatory Elements (4) 15 Results: Active Filter: Herzog, MargaretaJanz, Martin Dr.Leutz, Achim Prof. Dr.Lusatis, SimoneMüller, Thomas Dr.Biology of Malignant LymphomasProteome Dynamics20052006201020142021 Sort: Result score Newest to oldest Oldest to newest January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou May 01, 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas January 01, 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken February 01, 2014 / Genes Dev Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination M.E. Sheean E. McShane C. Cheret J. Walcher T. Müller A. Wulf-Goldenberg S. Hoelper A.N. Garratt M. Krüger K. Rajewsky D. Meijer W. Birchmeier G.R. Lewin M. Selbach C. Birchmeier September 22, 2021 / Nat Commun Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma H.C. Liang M. Costanza N. Prutsch M.W. Zimmerman E. Gurnhofer I.A. Montes-Mojarro B.J. Abraham N. Prokoph S. Stoiber S. Tangermann C. Lobello J. Oppelt I. Anagnostopoulos T. Hielscher S. Pervez W. Klapper F. Zammarchi D.A. Silva K.C. Garcia D. Baker M. Janz N. Schleussner F. Fend Š. Pospíšilová A. Janiková J. Wallwitz D. Stoiber I. Simonitsch-Klupp L. Cerroni S. Pileri L. de Leval D. Sibon V. Fataccioli P. Gaulard C. Assaf F. Knörr C. Damm-Welk W. Woessmann S.D. Turner A.T. Look S. Mathas L. Kenner O. Merkel Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
May 01, 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas
January 01, 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken
February 01, 2014 / Genes Dev Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination M.E. Sheean E. McShane C. Cheret J. Walcher T. Müller A. Wulf-Goldenberg S. Hoelper A.N. Garratt M. Krüger K. Rajewsky D. Meijer W. Birchmeier G.R. Lewin M. Selbach C. Birchmeier
September 22, 2021 / Nat Commun Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma H.C. Liang M. Costanza N. Prutsch M.W. Zimmerman E. Gurnhofer I.A. Montes-Mojarro B.J. Abraham N. Prokoph S. Stoiber S. Tangermann C. Lobello J. Oppelt I. Anagnostopoulos T. Hielscher S. Pervez W. Klapper F. Zammarchi D.A. Silva K.C. Garcia D. Baker M. Janz N. Schleussner F. Fend Š. Pospíšilová A. Janiková J. Wallwitz D. Stoiber I. Simonitsch-Klupp L. Cerroni S. Pileri L. de Leval D. Sibon V. Fataccioli P. Gaulard C. Assaf F. Knörr C. Damm-Welk W. Woessmann S.D. Turner A.T. Look S. Mathas L. Kenner O. Merkel